- BeiGene (NASDAQ:BGNE) initiated with Overweight rating and $39 (22% upside) price target by Morgan Stanley. Initiated with Outperform rating by Cowen & Co.
- Editas Medicine (NASDAQ:EDIT) initiated with Outperform rating and $40 (7% upside) price target by JMP Securities.
- Paratek Pharmaceuticals (NASDAQ:PRTK) initiated with Buy rating and $32 (100% upside) price target by H.C. Wainwright.
Healthcare ratings roundup - new coverage #2
Recommended For You
More Trending News
About BGNE Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BGNE | - | - |
| BeiGene, Ltd. | ||